(Q39296001)

10 September 2017

The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study (English)

1 reference

Acute decompensated heart failure

10 September 2017

0 references

0 references

1 reference

13

Karen Sliwa

1 reference

10 September 2017

Peter S Pang

2

0 references

Mihai Gheorghiade

17

object named as

Mihai Gheorghiade

1 reference

10 September 2017

15

Gerasimos Filippatos

1 reference

10 September 2017

1

Alexandre Mebazaa

1 reference

10 September 2017

6

Said Laribi

1 reference

10 September 2017

14

Etienne Gayat

1 reference

10 September 2017

5

Alan B Storrow

1 reference

10 September 2017

Miguel Tavares

3

1 reference

10 September 2017

Sean P Collins

4

1 reference

10 September 2017

Stephanie Andre

7

1 reference

10 September 2017

Daniel Mark Courtney

8

1 reference

10 September 2017

Jennifer Hasa

9

1 reference

10 September 2017

Jindrich Spinar

10

1 reference

10 September 2017

Josep Masip

11

1 reference

10 September 2017

William Frank Peacock

12

1 reference

10 September 2017

John G F Cleland

16

1 reference

10 September 2017

11 November 2009

1 reference

10 September 2017

European Heart Journal

1 reference

10 September 2017

31

1 reference

10 September 2017

7

1 reference

10 September 2017

832-841

1 reference

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

10 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

Practical applications of intravenous diuretic therapy in decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology--WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP458

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHP458

1 reference

release_o6fjxkzrurf33mjqqbljfkmmuu

10 September 2017

0 references

1 reference